Business ❯ Pharmaceutical Industry ❯ Market Trends

Drug Development

Investment Opportunities Clinical Trials GLP-1 Medications Healthcare Costs GLP-1 Market Orforglipron Strategic Alliances Competition Eli Lilly & Co. B2B Marketing

GLP‑1 Market Set to Balloon as Oral Pill Wins US Approval

US clearance of an oral GLP‑1 expands access while regulators and health systems confront supply strains, safety reports and care gaps.

FDA Maps New Paths for Rare-Disease Drug Evidence, Keeps Bar High

Novo Nordisk Halts Phase-3 Alzheimer’s Trial of Semaglutide After Failure to Slow Decline

Cipla Prepares to Enter India’s Weight Management Market as It Expands CNS and AMR Portfolios

Rising Use of Ozempic Raises Health, Ethical, and Social Concerns

Roche Accelerates Development of Promising Weight-Loss Pills